Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Low Grade Serous Ovarian Cancer × Paclitaxel × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 285 Fallopian Tube Neoplasms 133 Carcinoma, Ovarian Epithelial 109 Endometrial Neoplasms 80 Uterine Cervical Neoplasms 64 Neoplasms 23 Brenner Tumor 22 Peritoneal Neoplasms 21 Breast Neoplasms 21 Carcinoma, Non-Small-Cell Lung 20 Stomach Neoplasms 17 Recurrence 17 Uterine Neoplasms 12 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Colorectal Neoplasms 10 Testicular Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 9 Neoplasm Metastasis 9 Urinary Bladder Neoplasms 7 Testicular Germ Cell Tumor 7 Prostatic Neoplasms 7 Pancreatic Neoplasms 7 Melanoma 7 Lung Neoplasms 7 Neurotoxicity Syndromes 6 Esophageal Neoplasms 6 Central Nervous System Neoplasms 6 Carcinoma 6 Triple Negative Breast Neoplasms 5 Carcinosarcoma 5

Interventions

liposomal doxorubicin 1 defactinib 1 Paclitaxel 1 Letrozole 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06072781 2026-03-17

RAMP 301

Verastem, Inc.

Phase 3 Recruiting

Low Grade Serous Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡